About me
Dun is a diagnostics and regulatory expert uniquely positioned at the intersection of pharma, diagnostics, and regulation. At Eli Lilly, he provides critical guidance, interpretation, risk assessments, and troubleshooting on precision medicine strategy globally. He coordinates and executes global diagnostic regulatory engagements with health authorities to support successful clinical trials, product approvals, and launches. Passionate about advancing precision medicine, he works to improve patient care through technology, process, and regulatory innovation. He has also been a FDA lead reviewer, lab director, diagnostic developer and entrepreneur.
